Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial
- 14 June 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (12) , 1420-1429
Abstract
Preliminary evidence suggests that fermentable carbohydrate restriction might ameliorate functional gastrointestinal symptoms [FGS] in inflammatory bowel disease [IBD]. Our aim was to determine whether fermentable carbohydrates exacerbate FGS in IBD using a randomised, double-blinded, placebo-controlled, re-challenge trial. Patients with quiescent IBD and FGS responsive to a low FODMAP diet were allocated to a series of 3-day [d] fermentable carbohydrate challenges in random order [fructan, 12 g/d; galacto-oligosaccharides [GOS] 6 g/d; sorbitol, 6 g/d; and glucose placebo, 12 g/d], each separated by a washout period. Symptoms and stool output were measured daily during the challenges. Thirty-two patients with IBD, fulfilling criteria for irritable bowel syndrome, functional bloating, or functional diarrhoea, were recruited and data were available for 29 patients completing all arms [12 Crohn’s disease, 17 ulcerative colitis]. Significantly fewer patients reported adequate relief of FGS on the final day day of the fructan challenge [18/29, 62.1%] compared with glucose [26/29, 89.7%] [p = 0.033]. There was greater severity of pain [1.1 vs 0.5, p = 0.004], bloating [1.3 vs 0.6, p = 0.002], flatulence [1.5 vs 0.7, p = 0.004], and faecal urgency [0.9 vs 0.4, p = 0.014] on the final day of fructan challenge compared with glucose. At the relatively high doses used, fructans, but not GOS or sorbitol, exacerbated FGS in quiescent IBD. Further research is required to determine whether a low FODMAP diet reduces FGS in IBD and the degree of FODMAP restriction required for symptom improvement.Keywords
Funding Information
- National Institute of Health Research
This publication has 43 references indexed in Scilit:
- Immunological Properties of Inulin-Type FructansCritical Reviews in Food Science and Nutrition, 2014
- Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's diseaseGut, 2011
- Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel SyndromePLOS ONE, 2010
- Validation of a food frequency questionnaire to measure intakes of inulin and oligofructoseEuropean Journal of Clinical Nutrition, 2010
- Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndromeJournal of Gastroenterology and Hepatology, 2010
- Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colonAlimentary Pharmacology & Therapeutics, 2010
- Measurement of Short-Chain Carbohydrates in Common Australian Vegetables and Fruits by High-Performance Liquid Chromatography (HPLC)Journal of Agricultural and Food Chemistry, 2009
- Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled EvidenceClinical Gastroenterology and Hepatology, 2008
- The Functional Gastrointestinal Disorders and the Rome III ProcessGastroenterology, 2006
- Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonistAlimentary Pharmacology & Therapeutics, 1999